HCF
0.032
77.8%
SRN
0.001
-50%
MEU
0.11
54.9%
NES
0.005
-37.5%
CTN
0.003
50%
FBR
0.004
-20%
CHM
0.004
33.3%
MOH
0.008
-20%
ALV
0.084
27.3%
NOR
0.013
-18.8%
MRQ
0.005
25%
LML
0.009
-18.2%
TYX
0.005
25%
SPQ
0.009
-18.2%
AXI
0.016
23.1%
AYT
0.005
-16.7%
STV
0.011
22.2%
A11
0.165
-15.4%
BLU
0.006
20%
ADN
0.012
-14.3%
BNL
0.006
20%
M4M
0.006
-14.3%
MGU
0.006
20%
NFL
0.12
-14.3%
KKO
0.067
19.6%
SER
0.006
-14.3%
GLL
0.007
16.7%
TEM
0.006
-14.3%
LKE
0.091
15.2%
CP8
0.065
-13.3%
PHX
0.155
14.8%
AUV
0.014
-12.5%
PL9
0.008
14.3%
LSR
0.014
-12.5%
FEX
0.495
13.8%
SHE
0.007
-12.5%
GIB
0.058
13.7%
CC9
0.15
-11.8%
ARC
0.105
12.9%
PDI
0.622
-11.8%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific

AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH